New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For ILMN;RHHBY From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | all recent news | >>
July 30, 2015
05:57 EDTRHHBYRoche submits filing to FDA for companion diagnostic for NSCLC drug therapy
Roche announced it has submitted the cobas EGFR Mutation Test v2 for Premarket Approval, or PMA, to the FDA, as a companion diagnostic test for AZD9291, an AstraZeneca (AZN) investigational therapy for non-small cell lung cancer patients with an acquired resistant mutation. Patients with non-small cell lung cancer who have adenocarcinoma with tumor containing an EGFR sensitizing mutation show significant benefit from currently available EGFR TKI therapies. However, approximately two-thirds of these patients will relapse and develop drug resistance. In many cases, this resistance is caused by an acquired mutation called T790M. The cobas EGFR v2 test can aid clinicians to appropriately select NSCLC patients who have acquired the T790M mutation and are most likely to benefit from AstraZeneca's novel therapy.
July 29, 2015
10:36 EDTILMNLockheed Martin launches healthcare technology alliance
Lockheed Martin (LMT) announced the formation of a new healthcare technology alliance, combining the expertise of health IT providers, medical technology companies, and academic institutions to advance public health. The Lockheed Martin Healthcare Technology Alliance's founding members include: Cisco (CSCO), Cloudera, Illumina (ILMN), Intel (INTC) and Montgomery College. The members of the Lockheed Martin Healthcare Technology Alliance will collaborate on technology solutions that help improve care in rapidly evolving and growing areas of health technology such as those that: secure patient medical information; leverage advances in genomic research; and apply big data solutions to improve public health.
July 28, 2015
10:15 EDTILMNOptions with decreasing implied volatility
Subscribe for More Information
07:08 EDTRHHBYRoche introduced several diagnostic testing platforms at the AACC 2015
Subscribe for More Information
July 23, 2015
06:27 EDTRHHBYRoche CEO expects biosimilars in Europe by late 2017, Reuters reports
Subscribe for More Information
05:46 EDTRHHBYRoche expects FY15 sales to grow low- mid-single digits
Expects FY15 core EPS to grow ahead of sales at constant exchange rates. Roche expects to further increase dividend in Swiss francs.
05:45 EDTRHHBYRoche reports 1H15 core EPS CHF 7.22 vs. 7.57 last year
Subscribe for More Information
July 22, 2015
10:01 EDTILMNOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
08:58 EDTILMNIllumina weakness a buying opportunity, says Cowen
Subscribe for More Information
07:52 EDTILMNIllumina downgraded to Neutral from Buy at Janney Capital
07:44 EDTILMNIllumina price target lowered to $250 from $275 at Canaccord
Subscribe for More Information
05:45 EDTILMNIllumina should be bought on post-earnings selloff, says Mizuho
Subscribe for More Information
July 21, 2015
19:00 EDTILMNOn The Fly: After Hours Movers
Subscribe for More Information
16:24 EDTILMNIllumina drops sharply after results
Subscribe for More Information
16:16 EDTILMNIllumina reports Q2 cash flow from operations of $171M, free cash flow $130M
16:15 EDTILMNIllumina reports Q2 gross margin 69.8% vs. 67.1% a year ago
16:15 EDTILMNIllumina raises FY15 adjusted EPS view to $3.39-$3.45 from $3.36-$3.42
Subscribe for More Information
16:13 EDTILMNIllumina reports Q2 adjusted EPS 80c, consensus 77c
Subscribe for More Information
15:02 EDTILMNNotable companies reporting after market close
Subscribe for More Information
07:05 EDTRHHBYOphthotech names Shima as Chief Scientific Officer, Bjarke as CCO
Subscribe for More Information
1 | 2 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use